$BPMC can rise in the next days

١٥ يوليو ٢٠٢٠

Contextual immersion trading strategy idea.

Blueprint Medicines Corporation develops drugs of small molecule kinase inhibitors that target genomic drivers in genomically defined cancers, rare diseases, and cancer immunotherapy.

The share prose rose after the company had announced the deal with pharma giant Roche (RHHBY) to sell a cancer treatment, pralsetinib.

The demand for shares of the company still looks higher than the supply.

These and other conditions can cause a rise in the share price in the next days.

So I opened a long position from $79,21;
stop-loss — $76,47.

Information about take-profits will be later.

Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.

If you like my content, you can subscribe to the news and receive my fresh ideas.

Thanks for being with me!

٢٠ يوليو ٢٠٢٠

أغلقت الصفقة: تم الوصول لوقف الخسارة